-
EP3247365
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3247365
| EP3247365 - NOVEL IODOPHOR COMPOSITION AND METHODS OF USE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.01.2022 Database last updated on 27.07.2024 | |
| Former | Examination is in progress Status updated on 02.12.2019 | ||
| Former | Request for examination was made Status updated on 27.10.2017 | ||
| Former | The international publication has been made Status updated on 18.07.2017 | Most recent event Tooltip | 28.01.2022 | Application deemed to be withdrawn | published on 02.03.2022 [2022/09] | Applicant(s) | For all designated states Veloce BioPharma LLC 1007 N Federal Hwy No.E4 Fort Lauderdale, FL 33304 / US | [2017/48] | Inventor(s) | 01 /
CAPRIOTTI, Joseph 3006 Orange Grove Christiansted, VI 00821 / US | 02 /
CAPRIOTTI, Kara 7008 Lafayette Avenue Fort Washington, PA 19034 / US | 03 /
PELLETIER, Jesse 1400 NE Miami Gardens Drive Suite 203 Miami, FL 33179 / US | [2017/48] | Representative(s) | Lee, Nicholas John, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [N/P] |
| Former [2017/48] | Hart, Deborah Mary, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | Application number, filing date | 16740539.8 | 15.01.2016 | [2017/48] | WO2016US13660 | Priority number, date | US201562105613P | 20.01.2015 Original published format: US 201562105613 P | US201562187973P | 02.07.2015 Original published format: US 201562187973 P | [2017/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016118424 | Date: | 28.07.2016 | Language: | EN | [2016/30] | Type: | A1 Application with search report | No.: | EP3247365 | Date: | 29.11.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.07.2016 takes the place of the publication of the European patent application. | [2017/48] | Search report(s) | International search report - published on: | US | 28.07.2016 | (Supplementary) European search report - dispatched on: | EP | 29.06.2018 | Classification | IPC: | A61K31/79, A61K33/18, A61K47/18 | [2017/48] | CPC: |
A61K9/0014 (EP,CN,KR,US);
A61K9/06 (EP,CN,KR,US);
A61K47/38 (CN,KR,US);
A61K31/79 (EP,CN,KR,US);
A61K33/18 (EP,CN,KR,US);
A61K47/10 (EP,KR,US);
A61K47/20 (CN,KR,US);
A61K47/32 (EP,CN,US);
A61K47/58 (US);
A61K9/0034 (EP,CN,KR,US);
A61K9/0048 (EP,KR,US);
A61P15/00 (EP,CN);
A61P17/00 (EP,CN);
A61P17/10 (EP);
A61P17/12 (EP,CN);
A61P27/02 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P31/02 (EP);
A61P31/04 (EP,CN);
A61P31/10 (EP,CN);
A61P31/12 (EP,CN);
A61P31/20 (CN);
A61P33/10 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/48] | Title | German: | NEUARTIGE JODOPHORZUSAMMENSETZUNG UND VERFAHREN ZUR VERWENDUNG | [2017/48] | English: | NOVEL IODOPHOR COMPOSITION AND METHODS OF USE | [2017/48] | French: | NOUVELLE COMPOSITION IODOPHORE ET PROCÉDÉS D'UTILISATION | [2017/48] | Entry into regional phase | 20.07.2017 | National basic fee paid | 20.07.2017 | Search fee paid | 20.07.2017 | Designation fee(s) paid | 20.07.2017 | Examination fee paid | Examination procedure | 20.07.2017 | Examination requested [2017/48] | 20.07.2017 | Date on which the examining division has become responsible | 28.01.2019 | Amendment by applicant (claims and/or description) | 02.12.2019 | Despatch of a communication from the examining division (Time limit: M06) | 09.06.2020 | Reply to a communication from the examining division | 28.07.2020 | Despatch of a communication from the examining division (Time limit: M04) | 23.11.2020 | Reply to a communication from the examining division | 18.03.2021 | Despatch of a communication from the examining division (Time limit: M06) | 29.09.2021 | Application deemed to be withdrawn, date of legal effect [2022/09] | 21.10.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2022/09] | Fees paid | Renewal fee | 11.01.2018 | Renewal fee patent year 03 | 16.01.2019 | Renewal fee patent year 04 | 02.01.2020 | Renewal fee patent year 05 | 18.01.2021 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2007106381 (CLS PHARMACEUTICALS INC [US], et al) [Y] 1-15 * example 3 *; | [Y] - J. J. TARRAND ET AL, "Dimethyl Sulfoxide Enhances Effectiveness of Skin Antiseptics and Reduces Contamination Rates of Blood Cultures", JOURNAL OF CLINICAL MICROBIOLOGY, (20120501), vol. 50, no. 5, doi:10.1128/JCM.05106-11, ISSN 0095-1137, pages 1552 - 1557, XP055207851 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1128/JCM.05106-11 | International search | [Y]US2014271529 (STOGNIEW MARTIN [US], et al) [Y] 1-43 * ; paragraphs [0013], [0023], [0026]-[0027], [0034], [0058], [0068], [0078], [0087]-[0089], [0129], [0131], [0135], [0173], [0181]-[0182]; claims 1, 4-6, 8-10, 15 *; | [Y]WO2009151619 (FORESIGHT BIOTHERAPEUTICS INC [US], et al) [Y] 1-43 * page 3, lines 25-34; page 4, lines 1-12; page 5, lines 30-34; page 6, lines 32-34; page 7, lines 1-10 *; | [Y]US5516808 (SAWAYA ASSAD S [US]) [Y] 9-11, 14, 31-34, 37 * ; column 3, lines 23-33; claims 1, 5-6 *; | [Y]US2011217260 (SHANTHA TOTADA R [US], et al) [Y] 41, 43 * ; paragraphs [0052], [0054], [0113], [0117] * | by applicant | US2014205559 | WO2007106381 | - REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY, (19950000), pages 866 - 885 |